Blood and Blood Components Global Market Report 2021 Featuring American Red Cross, Australian Red Cross Blood Service, Abbott Laboratories, Blood Centers of America, and Becton, Dickinson & Co - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blood and Blood Components Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global blood and blood components market is expected to grow from $36.47 billion in 2020 to $38.43 billion in 2021 at a compound annual growth rate (CAGR) of 5.4%. The market is expected to reach $45.18 billion in 2025 at a CAGR of 4.1%.

Major players in the blood and blood components market are American Red Cross, Australian Red Cross Blood Service, Abbott Laboratories, Blood Centers of America, and Becton, Dickinson & Co.

The blood and blood components market consist of sales of blood and blood component. The market involves collection of donor's blood and segregating it into required components for the purpose of therapy.

The blood and blood components market covered in this report is segmented by product into whole blood, blood components. It is also segmented by end-users into hospitals, ambulatory surgical centers, others; by application into anemia, trauma & surgery, cancer treatment, bleeding disorders and by blood components into red blood cells, platelets, plasma, white blood cells.

The blood and blood components market is restrained by the growing risk of developing or transferring an infection while the blood is transmitted to the patients. The growing possibilities of developing any transfusion transmitted infection (TTI) is imposing a restriction on the growth of the market.

The fear of transfusion of diseases from the donor to the recipient, forces many customers to avoid using donated blood, thus hampering the growth of the blood and blood components market. The most common viral agents that can be transmitted through blood transfusion are Human Immunodeficiency Virus (HIV), hepatitis viruses, West Nile Virus (WNV), Human T-cell Lymphotrophic Viruses (HTLVs).

The most prominent trend that has been witnessed in the blood and blood components market is the growing number of collaborations between the players involved in the market. Companies are adopting partnerships and collaborations in order to expand their reach, increase customer base and generate awareness in the market.

For example, the American Red Cross collaborated with HealthStream with an aim of introducing new program for healthcare organizations. Similarly, the BloodCenter of Wisconsin collaborated with SysLogic Inc., to study how the RFID technology can be used to enhance safety of the patient while collecting and transfusing blood products.

The blood and blood components market is being driven by increasing incidence of trauma and road accidents. Sometimes, because of traumas such as hemorrhage, the volume of blood is reduced to a very low level and cannot be replaced fast enough by the body.

Also, road accidents cause excessive blood loss from the body that has to be restored immediately. At times, the blood itself lacks a few components as in the case of hemophilia. All these conditions demand transfusion of blood and blood components into the patient's body. The growing prevalence of diseases and increasing numbers of road accidents and traumas are increasing the demand for blood and thus driving the market.

The blood and blood components market in European Union is governed by Directive 2002/98/EC of the EU regulations. The regulatory body engages itself in providing guidelines and setting standards for quality and safety of collection, testing, processing, storage, and distribution of blood and blood components. These guidelines ensure greater quality and safety of whole blood and its components to prevent transmission of diseases and also highlight necessary measures for their collection and distribution.

Key Topics Covered:

1. Executive Summary

2. Blood and Blood Components Market Characteristics

3. Blood and Blood Components Market Trends and Strategies

4. Impact Of COVID-19 On Blood and Blood Components

5. Blood and Blood Components Market Size and Growth

5.1. Global Blood and Blood Components Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Blood and Blood Components Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Blood and Blood Components Market Segmentation

6.1. Global Blood and Blood Components Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Whole Blood
• Blood Components

6.2. Global Blood and Blood Components Market, Segmentation by End-Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Hospitals
• Ambulatory Surgical Centers
• Others

6.3. Global Blood and Blood Components Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Anemia
• Trauma & Surgery
• Cancer Treatment
• Bleeding Disorders

6.4. Global Blood and Blood Components Market, Segmentation by Blood Components, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Red blood cells
• Platelets
• Plasma
• White blood cells

7. Blood and Blood Components Market Regional and Country Analysis

7.1. Global Blood and Blood Components Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Blood and Blood Components Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

• American Red Cross
• Australian Red Cross Blood Service
• Abbott Laboratories
• Blood Centers of America
• Becton, Dickinson & Co.
• German Red Cross
• Nipro Medical Corporation
• American Association of Blood Banks
• AVIS National
• National Blood Authority Australia
• Vitalant
• Baxter International Inc.
• CSL Behring
• Immucor
• Novartis
• Novo Nordisk
• Ortho Clinical Diagnostics
• Roche Diagnostics
• Grifols International SA
• Medimmune (AstraZeneca)
• Fresenius Kabi
• Macopharma
• Sarstedt AG & Co.
• Thermo Fisher Scientific Inc.
• Terumo Corporation
• Sarstedt AG & Co.
• Haemonetics Corporation
• Medtronic Plc

For more information about this report visit https://www.researchandmarkets.com/r/vqzp0x